Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response

Michael Mynhardt; Nicaise Ndembi

doi:10.4081/jphia.2023.2861

Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response

J Public Health Afr. 2023 Oct 1;14(9):2861. doi: 10.4081/jphia.2023.2861.

Authors

Michael Mynhardt¹, Nicaise Ndembi²

Affiliations

¹ Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, Ndabeni, Cape Town 7405.
² Chief Science Advisor, Office of The Director General of The Africa Center for Disease Control and Prevention (Africa CDC), Souh Africa.

No abstract available

Keywords: HIV; World Health Organisation; healthcare systems; pandemic preparedness; pandemic response; pharmaceutical manufacturing in Africa; vaccine technology; viral suppression.

Publication types

Editorial